Severe cholestasis related to intraconazole for the treatment of onychomycosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10606333.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a case of prolonged cholestasis temporally associated with the use of itraconazole for onychomycosis. Peak bilirubin level of 32.0 mg/dl was documented approximately 2 months after discontinuation of the patient's itraconazole therapy, with symptoms of cholestasis persisting more than 1 month after the peak in bilirubin. Physicians should be aware of the potential for severe cholestasis associated with itraconazole usage.
Medical subject headings
- Antifungal Agents
- Cholestasis, Intrahepatic
- Itraconazole
- Onychomycosis